Literature DB >> 18022543

Tumor microenvironment and immune escape.

Soldano Ferrone1, Theresa L Whiteside.   

Abstract

This article describes the multiple escape mechanisms used by tumor cells to avoid T-cell-mediated recognition and destruction. The discussion focuses on escape mechanisms that may result from changes at the level of TA-specific cytotoxic T lymphocytes and tumor cells in the tumor microenvironment. Specifically, we discuss the negative impact of regulatory T cells and T-cell apoptosis on the tumor antigen-specific cytotoxic T lymphocyte response. We also discuss changes in the expression of histocompatibility antigens by tumor cells, which may affect tumor cell-immune cell interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18022543     DOI: 10.1016/j.soc.2007.08.004

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  35 in total

Review 1.  Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.

Authors:  Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

2.  Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.

Authors:  Martin Grimm; Oliver Feyen; Heiko Hofmann; Peter Teriete; Thorsten Biegner; Adelheid Munz; Siegmar Reinert
Journal:  Tumour Biol       Date:  2015-10-16

Review 3.  Immunological battlefield in gastric cancer and role of immunotherapies.

Authors:  Minyu Wang; Rita A Busuttil; Sharon Pattison; Paul J Neeson; Alex Boussioutas
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 4.  Immunotherapy as a Potential Treatment for Chordoma: a Review.

Authors:  Shalin S Patel; Joseph H Schwab
Journal:  Curr Oncol Rep       Date:  2016-09       Impact factor: 5.075

5.  Murine lung cancer induces generalized T-cell exhaustion.

Authors:  Rohit Mittal; Ching-Wen Chen; John D Lyons; Lindsay M Margoles; Zhe Liang; Craig M Coopersmith; Mandy L Ford
Journal:  J Surg Res       Date:  2015-02-12       Impact factor: 2.192

Review 6.  Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation.

Authors:  Magis Mandapathil; Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2011-06-26       Impact factor: 4.388

7.  Phase I dendritic cell p53 peptide vaccine for head and neck cancer.

Authors:  Patrick J Schuler; Malgorzata Harasymczuk; Carmen Visus; Albert Deleo; Sumita Trivedi; Yu Lei; Athanassios Argiris; William Gooding; Lisa H Butterfield; Theresa L Whiteside; Robert L Ferris
Journal:  Clin Cancer Res       Date:  2014-02-28       Impact factor: 12.531

8.  Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.

Authors:  Yiting Geng; Hui Wang; Changqing Lu; Qing Li; Bin Xu; Jingting Jiang; Changping Wu
Journal:  Int J Clin Oncol       Date:  2014-05-09       Impact factor: 3.402

9.  Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome.

Authors:  Barbara Vizio; Anna Novarino; Alice Giacobino; Carmen Cristiano; Adriana Prati; Libero Ciuffreda; Giuseppe Montrucchio; Graziella Bellone
Journal:  Exp Ther Med       Date:  2012-04-18       Impact factor: 2.447

10.  Unexpected high response rate to traditional therapy after dendritic cell-based vaccine in advanced melanoma: update of clinical outcome and subgroup analysis.

Authors:  Laura Ridolfi; Massimiliano Petrini; Laura Fiammenghi; Anna Maria Granato; Valentina Ancarani; Elena Pancisi; Emanuela Scarpi; Massimo Guidoboni; Giuseppe Migliori; Stefano Sanna; Francesca Tauceri; Giorgio Maria Verdecchia; Angela Riccobon; Linda Valmorri; Ruggero Ridolfi
Journal:  Clin Dev Immunol       Date:  2010-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.